Andere Sprachen Renalytix Plc Nasdaq

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
0,7001 ^USD	-7,76 %		+11,34 %	+79,51 %

18.04.	Renalytix Chief Business Officer wird zum Präsidenten ernannt	AN
18.04.	Renalytix plc kündigt Änderungen in der Geschäftsführung mit Wirkung zum 30. April 2024 an	CI

Pentwater Capital Management LP - Form 8.3 - Renalytix PLC	26.04.
Renalytix chief business officer to become president	18.04.
Renalytix Names Chief Business Officer as President	18.04.
Renalytix plc Announces Executive Changes, Effective from April 30, 2024	18.04.
Renalytix Issues New Shares for Convertible Bonds Repayment	10.04.
FTSE 100 Index Closes Up 0.4% Lifted by Miners	08.04.
Renalytix announces financing of up to USD4 million	08.04.
Renalytix to Raise Up to $4 Million via Share Offering	08.04.
Renalytix plc Announces Change of Registered Office Address	04.04.
Renalytix : Notification letter April 2024	03.04.
Form 8.5 (EPT/RI) - Renalytix plc	03.04.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	15.03.
Horizonte subsidiary hit with debt injunction	14.03.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	14.03.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	14.03.
Renalytix plc's KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease	14.03.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	13.03.
Pentwater Capital Management LP - Form 8.3 - Renalytix Plc	13.03.
ADRs End Higher, ATRenew Inc. Climbs 26.9%	12.03.
Renalytix Raises $12 Million via Equity Placing to Extend Cash Runway	12.03.

Keine Ergebnisse zu dieser Suche